Author/Creator: Sörensen, H - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Sörensen, H

1. Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Issue 11 (1st November 2002)

Authors:: Rudwaleit, M; Andermann, B; Alten, R; Sörensen, H; Listing, J; Zink, A; Sieper, J; Braun, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 61:Issue 11(2002)
Page Start:: 968
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Issue 4 (1st April 2001)

Authors:: Fendler, C; Laitko, S; Sörensen, H; Gripenberg-Lerche, C; Groh, A; Uksila, J; Granfors, K; Braun, J; Sieper, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 60:Issue 4(2001)
Page Start:: 337
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists. Issue 3 (8th September 2005)

Authors:: Kary, S; Worm, M; Audring, H; Huscher, D; Renelt, M; Sörensen, H; Ständer, E; Maaß, U; Lee, H; Sterry, W; Burmester, G-R
Journal:: Annals of the rheumatic diseases
Issue:: Volume 65:Issue 3(2006)
Page Start:: 405
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0063 Three months results of a double-blind placebo controlled, phase-iii clinical trial of infliximab in active ankylosing spondylitis. (1st June 2001)

Authors:: Brandt, J; Alten, R; Burmester, G; Gromnica-Ihle, E; Kellner, H; Schneider, M; Sörensen, H; Zeidler, H; Thriene, W; Sieper, J; Braun, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 60(2001)Supplement 1
Page Start:: A139
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Issue 3 (29th October 2007)

Authors:: Braun, J; Baraliakos, X; Listing, J; Fritz, C; Alten, R; Burmester, G; Krause, A; Schewe, S; Schneider, M; Sörensen, H; Zeidler, H; Sieper, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 67:Issue 3(2008)
Page Start:: 340
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Issue 2 (23rd September 2004)

Authors:: Braun, J; Brandt, J; Listing, J; Zink, A; Alten, R; Burmester, G; Gromnica-Ihle, E; Kellner, H; Schneider, M; Sörensen, H; Zeidler, H; Sieper, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 64:Issue 2(2005)
Page Start:: 229
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗